Journal
JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume 5, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s40425-017-0217-6
Keywords
FAK; Immunotherapy; Checkpoint blockade; Pancreatic cancer
Categories
Funding
- Cancer Research UK [20850, 22011] Funding Source: researchfish
Ask authors/readers for more resources
Immunotherapy has had remarkable success in the treatment of some cancer types. However, pancreatic cancer has remained largely refractory to immunotherapy, including immune checkpoint inhibitors. Recently, Jiang and colleagues identified a key role for FAK in regulating the composition of the fibrotic and immuno-suppressive pancreatic tumour niche, and showed that FAK inhibitors can be used in combination with immune checkpoint blockade and gemcitabine chemotherapy to significantly delay pancreatic tumour progression. This study further supports the use of FAK inhibitors in combination with immunotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available